Naomi Watts is a longtime activist for women's perimenopausal and menopausal health. She spoke to PEOPLE about learning how ...

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product ...

Launched VIZZ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net pr ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ ...

Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in clinical trials ...

Lake Oswego, OR - January 08, 2026 - PRESSADVANTAGE - At Tersigni Vision, a growing number of patients are asking ...

LENZ Therapeutics (LENZ) announced an exclusive distribution agreement for Lunatus to register and commercialize VIZZ for the ...

The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a ...

That wide-ranging impact is why Popular Science chose the drops as the 2025 Health category winner. This year’s list also ...

Investing.com -- LENZ Therapeutics (NASDAQ:LENZ) stock tumbled 25% on heavy volume Friday in New York after a case of retinal tear associated with its VIZZ eye drop appeared in the FDA’s adverse event ...